GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,724 | -31.4% | 11,614 | 0.0% | 0.00% | – |
| Q1 2023 | $24,389 | +58.5% | 11,614 | -14.7% | 0.00% | – |
| Q4 2022 | $15,384 | -30.1% | 13,614 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | +22.2% | 13,614 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -18.2% | 13,614 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -21.4% | 13,614 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -47.2% | 13,614 | 0.0% | 0.00% | – |
| Q3 2021 | $53,000 | +20.5% | 13,614 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | +46.7% | 13,614 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | -26.8% | 13,614 | -25.2% | 0.00% | – |
| Q4 2020 | $41,000 | -79.2% | 18,189 | -75.4% | 0.00% | – |
| Q3 2020 | $197,000 | -18.9% | 73,919 | -7.0% | 0.00% | – |
| Q2 2020 | $243,000 | +55.8% | 79,494 | 0.0% | 0.00% | – |
| Q1 2020 | $156,000 | -31.3% | 79,494 | 0.0% | 0.00% | – |
| Q4 2019 | $227,000 | -22.3% | 79,494 | 0.0% | 0.00% | – |
| Q3 2019 | $292,000 | -14.6% | 79,494 | -3.6% | 0.00% | – |
| Q2 2019 | $342,000 | -19.0% | 82,494 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $422,000 | +49.1% | 82,494 | 0.0% | 0.00% | – |
| Q4 2018 | $283,000 | -42.9% | 82,494 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $496,000 | -5.5% | 82,494 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $525,000 | +34.3% | 82,494 | 0.0% | 0.00% | – |
| Q1 2018 | $391,000 | +41.7% | 82,494 | 0.0% | 0.00% | – |
| Q4 2017 | $276,000 | +55.9% | 82,494 | 0.0% | 0.00% | – |
| Q3 2017 | $177,000 | -12.8% | 82,494 | 0.0% | 0.00% | – |
| Q2 2017 | $203,000 | +2.0% | 82,494 | -4.8% | 0.00% | – |
| Q1 2017 | $199,000 | +118.7% | 86,669 | -6.3% | 0.00% | – |
| Q4 2016 | $91,000 | -13.3% | 92,519 | 0.0% | 0.00% | – |
| Q3 2016 | $105,000 | -22.8% | 92,519 | 0.0% | 0.00% | – |
| Q2 2016 | $136,000 | +3.0% | 92,519 | 0.0% | 0.00% | – |
| Q1 2016 | $132,000 | -13.2% | 92,519 | 0.0% | 0.00% | – |
| Q4 2015 | $152,000 | -58.8% | 92,519 | -41.3% | 0.00% | – |
| Q3 2015 | $369,000 | -12.6% | 157,662 | +1.9% | 0.00% | – |
| Q2 2015 | $422,000 | -20.7% | 154,662 | -2.6% | 0.00% | -100.0% |
| Q1 2015 | $532,000 | -5.0% | 158,828 | -1.7% | 0.00% | 0.0% |
| Q4 2014 | $560,000 | -31.6% | 161,510 | -0.9% | 0.00% | 0.0% |
| Q3 2014 | $819,000 | -63.6% | 163,010 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $2,251,000 | -8.9% | 163,010 | +1.0% | 0.00% | -33.3% |
| Q1 2014 | $2,470,000 | +46.5% | 161,360 | -22.6% | 0.00% | +50.0% |
| Q4 2013 | $1,686,000 | -36.7% | 208,610 | -21.9% | 0.00% | 0.0% |
| Q3 2013 | $2,662,000 | +128.7% | 267,000 | -2.5% | 0.00% | +100.0% |
| Q2 2013 | $1,164,000 | – | 273,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |